[144] Tenet Healthcare Corporation New SEC Filing
Form 144 notice for proposed sale of securities. The filing reports an intended sale of 78,762 shares of Common stock through Fidelity Brokerage Services LLC on or about 09/10/2025 with an aggregate market value of $15,025,892.48. The shares were acquired on 08/31/2025 via restricted stock vesting from the issuer and the payment type is listed as compensation. The filing states there were no securities sold in the past three months. Several issuer identification fields (including the issuer name and SEC file number) are not populated in the provided content.
- None.
- None.
Insights
TL;DR: Routine insider Form 144 reporting a proposed sale of newly vested restricted shares through a broker.
The notice documents a proposed sale of restricted stock that vested on 08/31/2025 and is being sold through Fidelity Brokerage Services with an approximate sale date of 09/10/2025. The filing confirms no sales in the prior three months and includes a standard attestation about absence of undisclosed material adverse information. The filing lacks populated issuer identification fields in the provided content, which are typically required for clear public disclosure.
TL;DR: Administrative disclosure of insider sale; filing appears routine but missing issuer identifiers in this excerpt.
This Form 144 records the sale of common shares acquired via restricted stock vesting and designated as compensation. It follows procedural requirements by noting broker details and the seller's representation regarding material nonpublic information. The excerpt does not include the issuer's name or SEC file number, which limits standalone interpretability of the notice as provided.